Drug and Alcohol Dependence Journal

Overview
Identity
View All

publication venue for

Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. 234:109394. 2022
Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. 231:109254. 2022
Stimulant-related incident surveillance using emergency medical service records in Massachusetts, 2013–2020.. 235:109460. 2022
Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs. 221:108626. 2021
Elevated risk of substance use disorder and suicidal ideation among Black and Hispanic lesbian, gay, and bisexual adults. 226:108848. 2021
Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone. 228:108996. 2021
Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US. 226:108849. 2021
Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997-2017. 225:108797. 2021
Women-centered drug treatment models for pregnant women with opioid use disorder: A scoping review. 226:108855. 2021
Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky. 208:107837. 2020
Model and approach for assessing implementation context and fidelity in the HEALing Communities Study. 217:108330. 2020
Opioid initiation and injection transition in rural northern New England: A mixed-methods approach. 217:108256. 2020
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. 217:108335. 2020
The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US. 212:108067. 2020
A mixed-methods assessment of the impact of the opioid epidemic on first responder burnout. 205:107620. 2019
The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting. 205:107514. 2019
Touchpoints – Opportunities to predict and prevent opioid overdose: A cohort study. 204:107537. 2019
Feasibility of ecological momentary assessment to study mood and risk behavior among young people who inject drugs. 187:227-235. 2018
Sex work, injection drug use, and abscesses: Associations in women, but not men. 185:293-297. 2018
Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?. 190:170-178. 2018
Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. 174:128-136. 2017
A systematic review of the motivations for the non-medical use of prescription drugs in young adults. 162:3-25. 2016
Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence.. 159:181-9. 2016
Structural equation modeling of the effects of racism, LGBTQ discrimination, and internalized oppression on illicit drug use in LGBTQ people of color. 159:255-262. 2016
Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS. 148:47-55. 2015
Erratum to “Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, US: 1991–2012” [Drug Alcohol Depend. 143 (2014) 149–157]. 148:230-232. 2015
Gender differences in mortality among treated opioid dependent patients. 155:228-235. 2015
The role of social networks and geography on risky injection behaviors of young persons who inject drugs. 154:229-235. 2015
Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users. 140:69-77. 2014
Innovative alcohol use: Assessing the prevalence of alcohol without liquid and other non-oral routes of alcohol administration. 142:74-78. 2014
Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991–2012. 143:149-157. 2014
Prevalence of psychiatric disorders among young injection drug users. 124:70-78. 2012
Symptoms of substance dependence and risky sexual behavior in a probability sample of HIV-negative men who have sex with men in Chicago. 110:38-43. 2010
Associations among state and local organizational contexts: Use of evidence-based practices in the criminal justice system. 103:S23-S32. 2009
Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysis. 103:S43-S53. 2009
Competing values among criminal justice administrators: The importance of substance abuse treatment. 103:S7-S16. 2009
Filling service gaps: Providing intensive treatment services for offenders. 103:S33-S42. 2009
Measuring collaboration and integration activities in criminal justice and substance abuse treatment agencies. 103:S54-S64. 2009
Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system. 103:S1-S6. 2009
Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions. 103:S73-S81. 2009
A Rasch model analysis of evidence-based treatment practices used in the criminal justice system. 93:163-175. 2008
Polydrug use and implications for longitudinal research: Ten-year trajectories for heroin, cocaine, and methamphetamine users. 96:193-201. 2008
Measuring the stability of illicit drug markets: Why does it matter?. 90:S52-S60. 2007
Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. 91:S18-S29. 2007
The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. 87:164-174. 2007
Sequence of drug use among serious drug users: typical vs atypical progression. 45:185-196. 1997
Trust in a COVID-19 vaccine among people with substance use disorders. 2021

publisher

Elsevier BV Publisher